Endo - Diabetes Drugs Flashcards
Metformin - how does it work, what effect does it have on weight, and side effects?
Works - Increases insulin sensitivity and decreases liver production of glucose
Weight - weight neutral
Side effects - GI disturbances, lactic acidosis, does NOT CAUSE hypoglycaemia
Thiazolidinedione (pioglitazone) - how does it work, what effect does it have on weight, and side effects?
How does it work - increases insulin sensitivity and decreases liver production of glucose
Weight - weight gain
Notable side effects - weight gain, fluid retention, HF, increase risk of bladder cancer, fractures, anaemia
Does NOT CAUSE hypoglycaemia
Sulfonylurea - how does it work, what effect does it have on weight, and side effects?
Gliclazide
Works - stimulates insulin release from pancreas
Side effects - weight gain, hypoglycaemia, hyponatraemia secondary to SIADH, increased risk of MI and CV disease if used as monotherapy
Incretins (relevant for DPP-4 inhibitors and GLP-1 mimetics) - how do they work?
Incretins - hormones produced by GI tract, secreted in response to large meals and act to reduce blood sugar, they can:
- Increase insulin secretions
- Inhibit glucagon production
- Slow absorption by GI tract
Main incretin is glucagon-like peptide-1 (GLP-1)
Incretins inhibited by enzyme called dipeptidyl peptidase-4 (DPP-4)
DPP-4 inhibitor - how does it work, what effect does it have on weight, and side effects?
Example - Sitagliptin
Works - Inhibits DPP-4 enzyme, therfore increasing GLP-1 activity
Side effects - GI disturbances, symptoms of upper respiratory tract infection, pancreatitis
GLP-1 mimetics - how does it work, what effect does it have on weight, and side effects?
Example - exenatide, given as subcut injection BD, or once weekly in modifiable-release form
Side effects - GI disturbances, WEIGHT LOSS, dizziness, low risk of hypoglycaemia
SGLT-2 Inhibitors - how does it work, what effect does it have on weight, and side effects?
Example - end with ‘glifozin’, empaglifozin, canaglifozin, dapaglifozin
Works - SGLT-2 protein responsible for reabsorbing glucose from urine into blood in proximal tubules of kidneys, so SGLT-2 inhibitors block action of this protein, cause glucose to be excreted in urine
Side effects - Glucoseuria, increased UTIs, WEIGHT LOSS, DKA with only moderately raised glucose, lower limb amputation appears to be more comon in patients on canaglifozin